Please login to the form below

Not currently logged in
Email:
Password:

miRagen Therapeutics bolsters senior leadership team

Adam Levy and Christopher Mori take on new roles

miRagen Therapeutics Adam LevyColorado-based miRagen Therapeutics has expanded its senior leadership team with the appointments of Adam Levy as chief business officer, succeeding Christopher Mori who now becomes chief operating officer.

Levy (pictured right) joins the clinical-stage biopharmaceutical company from Wedbush Securities, a healthcare banking group, where he served as senior vice president from 2013.

Prior to this, Levy held positions of increasing responsibility in investment banking at Merrill Lynch and Jeffries, working primarily in the life sciences sector.

Meanwhile, Mori (pictured below) brings over 25 years of strategic and operational experience to his new role at miRagen Therapeutics.

Prior to joining as chief business officer, Mori served as interim chief financial officer at Alethia Biotherapeutics, where he currently serves as an independent director.

miRagen Christopher MoriHe has held a number of executive leadership positions, including chief operating officer at Ambit Biosciences Corporation and vice president of business development at Agensys, and spent 20 years at GlaxoSmithKline in a variety of roles.

Levy said: “With two novel programmes in the clinic and a focus on diseases with high unmet medical need, I believe miRagen is poised to make a difference in the lives of patients.

“I am excited to join this talented team and contribute to the success of miRagen Therapeutics as we develop our pipeline of product candidate across multiple disease areas.”

14th June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics